Remineralization Potential of Curodont Repair Flouride Plus Versus CPP-ACP in Management of White Spot Lesions: Randomized Clinical Trial
Launched by CAIRO UNIVERSITY · Jan 27, 2020
Trial Information
Current as of May 13, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 18 and 35 years of age female and males
- • Had received conventional periodontal therapy
- • Active carious white spot lesions
- • No systemic diseases or concomitant medication affecting salivary flow
- Exclusion Criteria:
- • - Participant in another trial
- • Non carious lesion (enamel hypoplasia and dental flourosis)
- • Presence of abnormal oral, medical, or mental condition.
- • Participants who had evidence of reduced salivary flow or significant tooth wear.
- • Allergy to MI paste
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials